| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/05/2013 | US8388971 Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses |
| 03/05/2013 | US8388966 Combination treatment of pancreatic cancer |
| 03/05/2013 | US8388949 Compositions comprising pantothenic acid and their use for stimulating appetite |
| 03/05/2013 | US8388946 Bacteriophage-containing therapeutic agents |
| 03/05/2013 | US8388939 Moisturizing cosmetic composition comprising a combination of homarine and erythritol |
| 03/05/2013 | US8388935 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 03/05/2013 | CA2711655C Condensed aminodihydrothiazine derivative |
| 03/05/2013 | CA2708324C Viral polymerase inhibitors |
| 03/05/2013 | CA2666258C Antidepressant, neuroprotectant, amyloid .beta. deposition inhibitor or age retardant containing heterocyclic compound having specific structure |
| 03/05/2013 | CA2628031C Once-daily administration of central nervous system drugs |
| 03/05/2013 | CA2619953C Anti-inflammatory activity of phenethylisothiocyanate (peitc) and the barbarea verna seed preparation containing this compound |
| 03/05/2013 | CA2574193C Benzothiazole derivatives as adenosine receptor ligands |
| 03/05/2013 | CA2569883C Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems |
| 03/05/2013 | CA2567703C 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide |
| 03/05/2013 | CA2554695C Solid formulations of ospemifene |
| 03/05/2013 | CA2552004C Methods for tailoring the immune response to an antigen or immunogen |
| 03/05/2013 | CA2539033C Treatment of disease or injury of the nervous system with fty720 |
| 03/05/2013 | CA2529320C Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases |
| 03/05/2013 | CA2427161C Use of bisphosphonates for pain treatment |
| 03/01/2013 | CA2844073A1 Policosanol nanoparticles |
| 02/28/2013 | WO2013029060A2 Compositions and methods for treating neurodegenerative disease |
| 02/28/2013 | WO2013029057A2 Compositions and methods for treating neurodegenerative disease |
| 02/28/2013 | WO2013029043A1 Selective kinase inhibitors |
| 02/28/2013 | WO2013029034A1 Tripartite bioactive composition providing anti-oxidant and anti-inflammatory effects with immune system and stem cell production enhancement |
| 02/28/2013 | WO2013029006A1 Dengue virus and yellow fever virus therapies |
| 02/28/2013 | WO2013028953A1 Combination treatments for hepatitis c |
| 02/28/2013 | WO2013028909A1 Combination therapy for the treatment of sleep-related breathing disorders |
| 02/28/2013 | WO2013028890A1 Compositions and methods for treating viral diseases |
| 02/28/2013 | WO2013028882A1 Treatment of symptoms associated with female gastroparesis |
| 02/28/2013 | WO2013028880A1 Use of zileuton for the treatment of nasal polyps in cystic fibrosis patients |
| 02/28/2013 | WO2013028866A1 Therapeutic compounds and methods |
| 02/28/2013 | WO2013028832A2 Inhibitors of nedd8-activating enzyme |
| 02/28/2013 | WO2013028818A1 Pyrimido- pyridazinone compounds and use thereof |
| 02/28/2013 | WO2013028715A1 Pyrano [3, 2 - d] [1, 3] thiazole as glycosidase inhibitors |
| 02/28/2013 | WO2013028670A1 2-spiro-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions and their use |
| 02/28/2013 | WO2013028587A1 1,4-diazabicyclo[3.2.2]nonanes as neuronal nicotinic acetylcholine receptor ligands |
| 02/28/2013 | WO2013028572A1 Fluorinated bisphenol ether compounds and methods for their use |
| 02/28/2013 | WO2013028570A2 Meta-substituted biphenyl peripherally restricted faah inhibitors |
| 02/28/2013 | WO2013028543A1 Bax agonist, compositions, and methods related thereto |
| 02/28/2013 | WO2013028505A1 Combination cancer therapy of hsp90 inhibitor with antimetabolite |
| 02/28/2013 | WO2013028501A1 Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system |
| 02/28/2013 | WO2013028495A1 Dihydropyridophthalazinone inhibitors of poly (adp-ribose) polymerase (parp) for the treatment of multiple myeloma |
| 02/28/2013 | WO2013028474A1 Inhibitors of the renal outer medullary potassium channel |
| 02/28/2013 | WO2013028471A1 Methods and intermediates for preparing macrolactams |
| 02/28/2013 | WO2013028470A1 Process and intermediates for preparing macrolactams |
| 02/28/2013 | WO2013028371A1 Benzofuran compounds for the treatment of hepatitis c virus infections |
| 02/28/2013 | WO2013028297A1 Compositions and methods for treating herpes viruses |
| 02/28/2013 | WO2013028263A1 Pyrazolopyrimidine derivatives as pi3 kinase inhibitors |
| 02/28/2013 | WO2013028082A1 Antimicrobial composition |
| 02/28/2013 | WO2013028051A1 Composition comprising sandoricum koetjape extracts and uses thereof |
| 02/28/2013 | WO2013028032A1 Preparation for percutaneous absorption and method for preparing same |
| 02/28/2013 | WO2013027986A2 Method of screening for chaperonin modulator |
| 02/28/2013 | WO2013027932A1 Pharmaceutical composition for preventing or treating premature ejaculation comprising 8-hydroxyclomipramine or its salt |
| 02/28/2013 | WO2013027895A1 Composition for inhibiting angiogenesis containing a peroxidasin inhibitor as an active ingredient |
| 02/28/2013 | WO2013027845A1 Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (pde10a) in mammals |
| 02/28/2013 | WO2013027840A1 Hydrous adhesive skin patch |
| 02/28/2013 | WO2013027835A1 Method for producing optically active naphthalene compound |
| 02/28/2013 | WO2013027806A1 Pharmaceutical composition for preventing or treating underactive bladder |
| 02/28/2013 | WO2013027801A1 Fused heterocyclic derivative and pharmaceutical use thereof |
| 02/28/2013 | WO2013027794A1 Novel compound and use thereof as pde10 inhibitor |
| 02/28/2013 | WO2013027681A1 Transdermal patch |
| 02/28/2013 | WO2013027222A1 (bacterio)chlorophyll photosensitizers for treatment of eye diseases and disorders |
| 02/28/2013 | WO2013027196A1 Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4- tetrahydroisoquinoline-4-carboxamides for antimalarial therapies |
| 02/28/2013 | WO2013027188A1 2 -amino-4 - (pyridin- 2 -yl) - 5, 6 -dihydro-4h- 1, 3 -oxazine derivatives and their use as bace-1 and/or bace - 2 inhibitors |
| 02/28/2013 | WO2013027184A1 Fish anesthetic and method |
| 02/28/2013 | WO2013027168A1 Novel heterocyclic compounds as bromodomain inhibitors |
| 02/28/2013 | WO2013027150A1 Compositions and methods for the treatment of parkinson's disease |
| 02/28/2013 | WO2013027073A1 Histamine h3 antagonist steroidal carboxamides |
| 02/28/2013 | WO2013027065A1 Ophthalmic formulations |
| 02/28/2013 | WO2013027063A1 Chemically programmable immunity |
| 02/28/2013 | WO2013027052A1 A device for the transdermal delivery of alkaline compounds that are susceptible to degradation in their free base form |
| 02/28/2013 | WO2013027040A1 Cyclic oligosaccharides for use in the treatment and prevention of bacterial infection |
| 02/28/2013 | WO2013027001A1 Compounds and their use to treat histamine h3 related disorders |
| 02/28/2013 | WO2013027000A1 Pyridazinone compounds and their use as daao inhibitors |
| 02/28/2013 | WO2013026947A1 Light-controlled activation and internalisation of small molecules that can bind to double-stranded dna |
| 02/28/2013 | WO2013026942A1 Tubulin binding agents |
| 02/28/2013 | WO2013026914A1 Serine/threonine pak1 inhibitors |
| 02/28/2013 | WO2013026897A1 Epicatechin for alleviating symptoms of allergy |
| 02/28/2013 | WO2013026874A1 Cdk9 inhibitors in the treatment of midline carcinoma |
| 02/28/2013 | WO2013026852A2 Derivatives of mecamylamine |
| 02/28/2013 | WO2013026806A1 Dyrk1 inhibitors and uses thereof |
| 02/28/2013 | WO2013026797A1 Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma |
| 02/28/2013 | WO2013026787A1 Fentanyl derivatives as ph-dependent opioid receptor agonists |
| 02/28/2013 | WO2013026772A1 Flurbiprofen and related compounds for the treatment of skin diseases |
| 02/28/2013 | WO2013026755A1 Methods and compounds for reducing allergic reactions to fragranced products and perfumes |
| 02/28/2013 | WO2013026694A1 Pharmaceutical compositions comprising voriconazole |
| 02/28/2013 | WO2013026587A1 1,4 disubstituted pyrrolidine - 3 - yl -amine derivatives and their use for the treatment of metabolic disorders |
| 02/28/2013 | WO2013026558A2 Combined therapeutic agent |
| 02/28/2013 | WO2013026557A1 Vasoconstrictor-containing agent for combination therapy |
| 02/28/2013 | WO2013026556A1 Monoterpene-containing agent for combination therapy |
| 02/28/2013 | WO2013026553A1 Composition comprising edoxaban |
| 02/28/2013 | WO2013026547A1 Rotigotine in the treatment of hemispatial neglect and other deficits following stroke |
| 02/28/2013 | WO2013026516A1 Bicyclic heteroaromatic compounds |
| 02/28/2013 | WO2013026455A1 Permanently positively charged antidepressants |
| 02/28/2013 | WO2013026454A1 Treatment of clinical conditions with anthracyclines |
| 02/28/2013 | WO2013026453A1 Treatment of inflammatory disorders with anthracyclines |
| 02/28/2013 | WO2013026383A1 Tetrandrine derivatives with substituted 5-carbon, preparation method and use thereof |
| 02/28/2013 | WO2013026373A1 Use of berbamine for treating chronic myeloid leukemia |
| 02/28/2013 | WO2013026270A1 Use of dexibuprofen levocetirizine double-layer sustained release tablet in treatment of airway inflammation |
| 02/28/2013 | WO2013026269A1 Method for preparing metered dose sprayed inhaler for treating respiratory disease |